On May 15, 2025, Fulgent Genetics, Inc. held its Annual Meeting where shareholders voted on board member elections and the appointment of Deloitte & Touche LLP as auditors; about 82% of eligible shares participated. Key votes included 19.3M for Ming Hsieh as director and 25.2M approving Deloitte as auditors.